Back to search
FDAFDA · Food and drugs·Recall number D-0075-2022

Advance Formula Pain Reliever (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets Per Packet, Packaged in 12,000 Packets/Case, PO# 007564-00, Item# 1170, Mfg. for: Advanced First Aid, Baltimore, MD 21237; American Safety & First Aid, Osceola, IN 46561 (Shipping Label)

Published November 3, 2021 · Recall initiated: October 13, 2021

Summary

FDA records drug Class III recall D-0075-2022, published November 3, 2021 and initiated October 13, 2021. Recalling firm: Ultra Seal Corporation; Status: Terminated; Reported quantity: 991,310 tablets; Lot: Lot #: AK-9457, exp. date 22-Jan; AK-9521, exp. date 22-Mar; AK-9959, exp. date 22-Dec; AK-1017, exp. date 23-Jan. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ultra Seal Corporation
Distributor
Nationwide in the USA.
Lot
Lot #: AK-9457, exp. date 22-Jan; AK-9521, exp. date 22-Mar; AK-9959, exp. date 22-Dec; AK-1017, exp. date 23-Jan
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Advance Formula Pain Reliever (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets Per Packet, Packaged in 12,000 Packets/Case, PO# 007564-00, Item# 1170, Mfg. for: Advanced First Aid, Baltimore, MD 21237; American Safety & First Aid, Osceola, IN 46561 (Shipping Label) recalled?

Yes. FDA published recall D-0075-2022 on November 3, 2021. Reported hazard: Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

What should I do if I have this product?

Voluntary: Firm initiated · Letter